Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Linda van Dreunen"'
Autor:
Josephine D. Kahn, Martine E.D. Chamuleau, Theresa M. Westers, Peter M. Van de Ven, Linda van Dreunen, Margot van Spronsen, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht
Publikováno v:
Haematologica, Vol 100, Iss 6 (2015)
Externí odkaz:
https://doaj.org/article/47f3ad1d13a1469b9cfb93910ee30a3f
Autor:
Martine E.D. Chamuleau, Theresia M. Westers, Linda van Dreunen, Judith Groenland, Adri Zevenbergen, Corien M. Eeltink, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht
Publikováno v:
Haematologica, Vol 94, Iss 4 (2009)
Background An activated immune system has been observed in patients with myelodysplastic syndrome but its exact contribution to disease development and control is not fully clarified. On the one hand an activated and skewed T-cell repertoire has been
Externí odkaz:
https://doaj.org/article/d8cce6d5de1e4ecfacffca1af507e296
Autor:
Margot F. van Spronsen, Linda van Dreunen, Martine E.D. Chamuleau, Theresa M. Westers, Josephine D. Kahn, Peter M. van de Ven, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht
Publikováno v:
Kahn, J D, Chamuleau, M E D, Westers, T M, van de Ven, P M, van Dreunen, L, van Spronsen, M F, Ossenkoppele, G J & van de Loosdrecht, A A 2015, ' Regulatory T cells and progenitor B cells are independent prognostic predictors in lower risk myelodysplastic syndromes ', Haematologica, vol. 100, no. 6, pp. E220-E222 . https://doi.org/10.3324/haematol.2014.116657
Haematologica, 100(6), E220-E222. Ferrata Storti Foundation
Haematologica, 100(6), E220-E222. Ferrata Storti Foundation
Research has provided evidence for immune surveillance in patients with myelodysplastic syndromes (MDS). However, while the presence of immune surveillance in MDS has been observed, little is known about its prognostic implications. This study aimed
Autor:
Theresia M. Westers, Arjan A. van de Loosdrecht, Martine E.D. Chamuleau, Adri Zevenbergen, Gert J. Ossenkoppele, Linda van Dreunen, Corien Eeltink, Judith Groenland
Publikováno v:
Chamuleau, M E D, Westers, T M, van Dreunen, L, Groenland, J, Zevenbergen, A, Eeltink, C M, Ossenkoppele, G J & van de Loosdrecht, A A 2009, ' Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome ', Haematologica, vol. 94, no. 4, pp. 496-506 . https://doi.org/10.3324/haematol.13612
Haematologica, 94(4), 496-506. Ferrata Storti Foundation
Haematologica, 94(4), 496-506. Ferrata Storti Foundation
Background An activated immune system has been observed in patients with myelodysplastic syndrome but its exact contribution to disease development and control is not fully clarified. On the one hand an activated and skewed T-cell repertoire has been
Publikováno v:
Blood. 116:203-203
Abstract 203 Chronic myeloid leukemia (CML) is well responsive to various therapeutic strategies, including conventional chemotherapy, tyrosine kinase inhibitors (TKI), but also allogeneic stem cell transplantation combined with donor lymphocyte infu
Publikováno v:
Blood. 114:857-857
Abstract 857 Tyrosine kinase inhibitors (TKI) like imatinib and dasatinib are the current treatment of choice for patients with chronic myeloid leukemia (CML). Although most patients enter a complete remission during treatment, cure of the disease is
Autor:
Martine E.D. Chamuleau, Adri Zevenbergen, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Linda van Dreunen, S.M.G. Jirka
Publikováno v:
Blood. 112:2946-2946
In vivo, effector T cells and NK cells do express membrane-bound TRAIL (TNF-related apoptosis-inducing ligand). T cells also secrete a soluble form of TRAIL (sTRAIL). Binding of TRAIL to one of the receptors on target cells can induce apoptosis. In h
Autor:
Linda van Dreunen, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk, Marleen M. van Loenen, Roel Willemze, Inge Jedema
Publikováno v:
Blood. 110:1809-1809
Allogeneic stem cell transplantation can be successfully applied in the treatment of hematological malignancies and relies on the graft versus leukemia (GVL) effect mediated by donor T cells directed against minor histocompatibility antigens (mHag) s
Autor:
Martine E.D. Chamuleau, Adri Zevenbergen Ing, Theresia M. Westers Ing, Judith Groenland, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Corien Eeltink, Linda van Dreunen
Publikováno v:
Blood. 110:4603-4603
The immune system plays a role in the pathogenesis of myelodysplastic syndrome (MDS) but its precise contribution to disease development and control is not fully clarified. T cell activation could reflect undesired autoimmune reactions against normal